SecBot SecBot
SECBOTREPLAY Home › Report › KROS

KROS · Two Keros Therapeutics directors sold a combined $56K in open-market…

Keros Therapeutics, Inc. · CLUSTER filed Jun 8, 2026 at 16:36 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 8, 2026 at 16:36 ET

Two Keros Therapeutics directors sold a combined $56K in open-market sales on June 4, 2026, following a round of non-cash stock grants to the same directors on June 3. The sales are trivial relative to the $204M market cap (0.03%) and are likely liquidity-driven after the grants, not a bearish signal. The cluster is not amplified by any cross-filing context (no earnings, offering, or late-filing events nearby).

  • Two directors (Seth Alpna and Knowles Julius) each sold 2,625 shares on June 4, 2026, at ~$10.72-$10.73, totaling $56,306.
  • Both sales occurred one day after each director received non-cash stock grants (7,433 and 7,142 shares respectively) on June 3, 2026.
  • Total sale value of $56K represents only 0.03% of KROS's $204M market cap, well below the 0.1% materiality threshold.
  • No C-suite executives participated in the sales; only two directors sold.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access